AZD0530, AN INHIBITOR OF SRC KINASES, IN PLATINUM-PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A TRIAL OF THE PMH PHASE II CONSORTIUM

被引：0
|
作者：
Laurie, Scott A. [1 ]
Goss, Glenwood D. [1 ]
Shepherd, Frances A. [2 ]
Reaume, Neil [1 ]
Nicholas, Garth [1 ]
Philip, Lindsay [2 ]
Wang, Lisa [2 ]
Oza, Amit [2 ]
Hirsh, Vera [3 ]
Wright, James
Leighl, Natasha [2 ]
机构：
[1] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON, Canada
[3] Mcgill Univ Hlth Ctr, Dept Oncol, Montreal, PQ, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
src kinase inhibitor; non-small cell; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1262 / S1262
页数：1
相关论文
共 50 条
  • [31] Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer
    Cheryl Ho
    Angela M. Davies
    Randeep S. Sangha
    Derick Lau
    Primo Lara
    Helen K. Chew
    Laurel Beckett
    Philip C. Mack
    Jonathan W. Riess
    David R. Gandara
    Investigational New Drugs, 2013, 31 : 1587 - 1591
  • [32] PHASE II STUDY OF A NOVEL TAXANE (CABAZITAXEL-XRP 6258) IN PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS: TOXICITY REPORT
    Bordoni, Rodolfo
    Robert, Francisco
    Saleh, Mansoor
    Dixon, Pamela
    Howell, Barbara
    Griffith, Candice
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1181 - S1181
  • [33] CONCURRENT CHEMORADIOTHERAPY (CCTRT) FOR LOCALLY ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) FOLLOWED BY CONSOLIDATION PEMETREXED: A PHASE II STUDY
    Faivre-Finn, Corinne
    Mccloskey, Paula
    Helbrow, Jonathan
    Bayman, Neil
    Burt, Paul
    Chittalia, Abbas
    Harris, Maggie
    Lee, Lip W.
    Pemberton, Laura
    Sheikh, Hamid
    Coote, Jo
    Taylor, Paul
    Ashcroft, Linda
    Scharf, Craig
    Halkyard, Emma
    Fenemore, Jackie
    Coyne, Tracy
    Blackhall, Fiona
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S852 - S852
  • [34] Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer
    Besse, Benjamin
    Planchard, David
    Veillard, Anne-Sophie
    Taillade, Laurent
    Khayat, David
    Ducourtieux, Muriel
    Pignon, Jean-Pierre
    Lumbroso, Jean
    Lafontaine, Carole
    Mathiot, Claire
    Soria, Jean-Charles
    LUNG CANCER, 2012, 76 (01) : 78 - 83
  • [35] Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer
    Vansteenkiste, J
    Canon, JL
    Riska, H
    Pirker, R
    Peterson, P
    John, W
    Mali, P
    Lahn, M
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (03) : 263 - 269
  • [36] Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
    S Novello
    G V Scagliotti
    R Rosell
    M A Socinski
    J Brahmer
    J Atkins
    C Pallares
    R Burgess
    L Tye
    P Selaru
    E Wang
    R Chao
    R Govindan
    British Journal of Cancer, 2009, 101 : 1543 - 1548
  • [37] Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer
    Johan Vansteenkiste
    Jean-Luc Canon
    Henrik Riska
    Robert Pirker
    Patrick Peterson
    William John
    Pekka Mali
    Michael Lahn
    Investigational New Drugs, 2005, 23 : 263 - 269
  • [38] Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
    Novello, S.
    Scagliotti, G. V.
    Rosell, R.
    Socinski, M. A.
    Brahmer, J.
    Atkins, J.
    Pallares, C.
    Burgess, R.
    Tye, L.
    Selaru, P.
    Wang, E.
    Chao, R.
    Govindan, R.
    BRITISH JOURNAL OF CANCER, 2009, 101 (09) : 1543 - 1548
  • [39] A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer
    Joppert, MG
    Garfield, DH
    Gregurich, MA
    Nemunaitis, JJ
    Marsland, TA
    Khandelwal, P
    Asmar, L
    LUNG CANCER, 2003, 39 (02) : 215 - 219
  • [40] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Kogure, Yoshihito
    Ando, Masahiko
    Yoshioka, Hiroshige
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Saka, Hideo
    IN VIVO, 2019, 33 (01): : 163 - 166
12345